Rosas Cancio-Suárez Marta, Díaz-Álvarez Jorge, Ron Raquel, Martínez-Sanz Javier, Serrano-Villar Sergio, Moreno Santiago, Sánchez-Conde Matilde
Infectious Diseases Department, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.1, 28034 Madrid, Spain.
Ramón y Cajal Research Institute (IRYCIS), 28034 Madrid, Spain.
Pathogens. 2023 Jul 9;12(7):924. doi: 10.3390/pathogens12070924.
Pre-exposure prophylaxis (PrEP) is a highly effective HIV-prevention strategy that involves the continuous administration of antiretroviral drugs to HIV-negative individuals with a substantial risk of contracting an HIV infection. The use of PrEP has shown a reduction in the risk of HIV acquisition through sexual intercourse by up to 99%. Despite its effectiveness, PrEP uptake remains low among populations at high risk of HIV infection. This highlights the need for further research in strategies to enhance awareness and uptake of PrEP amongst these specific populations. This article presents a comprehensive overview of the existing literature on the effectiveness of PrEP in reducing HIV transmission rates. Additionally, we examine the obstacles related to PrEP implementation and uptake and put forward potential strategies to raise awareness and improve its use among populations at an increased risk of contracting HIV.
暴露前预防(PrEP)是一种高效的艾滋病毒预防策略,涉及对有感染艾滋病毒重大风险的艾滋病毒阴性个体持续服用抗逆转录病毒药物。使用PrEP已显示通过性行为感染艾滋病毒的风险降低了99%。尽管其有效性显著,但在艾滋病毒高风险人群中,PrEP的使用率仍然很低。这凸显了在这些特定人群中进一步研究提高PrEP知晓率和使用率策略的必要性。本文全面概述了关于PrEP在降低艾滋病毒传播率方面有效性的现有文献。此外,我们研究了与PrEP实施和使用相关的障碍,并提出了提高知晓率以及在感染艾滋病毒风险增加的人群中改善其使用情况的潜在策略。